Literature DB >> 921578

Foveal lesions seen in retinitis pigmentosa.

G A Fishman, J M Maggiano, M Fishman.   

Abstract

A total of 110 patients with retinitis pigmentosa were prospectively and consecutively evaluated for the presence of foveal lesions. Of these 69 (63 percent) patients showed one of two types of separate and distinct bilateral foveal lesions. Forty-seven (43 percent) patients had atrophic-appearing lesions of the retinal pigment epithelium within the fovea of both eyes, and an additional 22 (20 percent) patients showed bitalteral foveal cysts or partial-thickness holes. Of the 22 patients in this last group, 16 showed cystoid macular edema evident on fluorescein angiography.

Entities:  

Mesh:

Year:  1977        PMID: 921578     DOI: 10.1001/archopht.1977.04450110087008

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  23 in total

1.  Visual acuity is related to parafoveal retinal thickness in patients with retinitis pigmentosa and macular cysts.

Authors:  Michael A Sandberg; Robert J Brockhurst; Alexander R Gaudio; Eliot L Berson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-14       Impact factor: 4.799

2.  Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors.

Authors:  Buğra Karasu
Journal:  Int Ophthalmol       Date:  2019-11-26       Impact factor: 2.031

3.  Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa.

Authors:  Gerald A Fishman; Marsha A Apushkin
Journal:  Br J Ophthalmol       Date:  2007-01-10       Impact factor: 4.638

4.  The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa.

Authors:  Yasuhiro Ikeda; Toshio Hisatomi; Noriko Yoshida; Shoji Notomi; Yusuke Murakami; Hiroshi Enaida; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-04       Impact factor: 3.117

5.  Phenotypic characterization of a large family with RP10 autosomal-dominant retinitis pigmentosa: an Asp226Asn mutation in the IMPDH1 gene.

Authors:  Petra Kozma; Dianna K Hughbanks-Wheaton; Kirsten G Locke; Garry E Fish; Anisa I Gire; Catherine J Spellicy; Lori S Sullivan; Sara J Bowne; Stephen P Daiger; David G Birch
Journal:  Am J Ophthalmol       Date:  2005-10-07       Impact factor: 5.258

6.  Retinitis pigmentosa: clinical observations and correlations.

Authors:  R C Pruett
Journal:  Trans Am Ophthalmol Soc       Date:  1983

7.  Cystoid macular edema of nonretinal vascular origin.

Authors:  B E Wright
Journal:  Bull N Y Acad Med       Date:  1982-09

8.  Macular abnormalities in the reattached retina.

Authors:  P E Cleary; P K Leaver
Journal:  Br J Ophthalmol       Date:  1978-09       Impact factor: 4.638

9.  Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa.

Authors:  Giuseppe Querques; Francesco Prascina; Cristiana Iaculli; Nicola Delle Noci
Journal:  Int Ophthalmol       Date:  2007-12-22       Impact factor: 2.031

10.  Cystoid macular edema in retinitis pigmentosa patients without associated macular thickening.

Authors:  Ian R Gorovoy; Denise S Gallagher; Andrew W Eller; Vera A Mayercik; Thomas R Friberg; Joel S Schuman
Journal:  Semin Ophthalmol       Date:  2013-03       Impact factor: 1.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.